In the field of respiratory health, Pipazetate, identified by CAS 2167-85-3, stands out as a compound with significant therapeutic and research value. Its classification as a non-narcotic oral antitussive agent means it effectively suppresses coughs by acting centrally on the cough center, offering a safer alternative to opioid-based treatments. This mechanism of action is crucial for developing treatments for chronic cough and other respiratory ailments. Furthermore, Pipazetate's role as a pharmaceutical intermediate is vital for innovation in respiratory medicine. It serves as a critical building block for synthesizing new drug candidates that may offer enhanced efficacy or novel therapeutic approaches for various lung conditions. The reliable supply of high-quality Pipazetate is paramount for driving progress in this area. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated supplier of Pipazetate, ensuring that researchers and pharmaceutical companies have access to this essential compound. Our commitment to quality means that every batch of Pipazetate meets stringent standards, facilitating breakthroughs in respiratory health. We understand the importance of this chemical compound in the journey from laboratory research to clinical application. By providing Pipazetate, we aim to support the development of next-generation treatments that can improve the quality of life for individuals suffering from respiratory diseases. Investing in Pipazetate means investing in the future of respiratory health innovation, and NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner in this endeavor.